<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="priority-pathogens">
<title>Zika • priority-pathogens</title>
<!-- favicons --><link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
<link rel="apple-touch-icon" type="image/png" sizes="180x180" href="../apple-touch-icon.png">
<link rel="apple-touch-icon" type="image/png" sizes="120x120" href="../apple-touch-icon-120x120.png">
<link rel="apple-touch-icon" type="image/png" sizes="76x76" href="../apple-touch-icon-76x76.png">
<link rel="apple-touch-icon" type="image/png" sizes="60x60" href="../apple-touch-icon-60x60.png">
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Zika">
<meta property="og:description" content="priority-pathogens">
<meta property="og:image" content="/logo.png">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">priority-pathogens</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">3.0.0</small>

    
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="active nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-articles">Articles</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-articles">
    <a class="dropdown-item" href="../articles/pathogen_lassa.html">Lassa fever (LASV)</a>
    <a class="dropdown-item" href="../articles/pathogen_marburg.html">Marburg Virus Disease (MVD)</a>
    <a class="dropdown-item" href="../articles/pathogen_sars.html">Severe acute respiratory syndrome (SARS)</a>
    <a class="dropdown-item" href="../articles/pathogen_zika.html">Zika</a>
  </div>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/mrc-ide/priority-pathogens/" aria-label="github">
    <span class="fab fa fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="../logo.png" class="logo" alt=""><h1>Zika</h1>
            
            <h4 data-toc-skip class="date">Latest update:
2026-01-07</h4>
      
      <small class="dont-index">Source: <a href="https://github.com/mrc-ide/priority-pathogens/blob/HEAD/vignettes/pathogen_zika.Rmd" class="external-link"><code>vignettes/pathogen_zika.Rmd</code></a></small>
      <div class="d-none name"><code>pathogen_zika.Rmd</code></div>
    </div>

    
    
<p>In 2018, the World Health Organization (WHO) published a list of nine
known pathogens (in addition to an unknown <em>Pathogen X</em>) for
research and development (R&amp;D) prioritisation, due to both their
epidemic and pandemic potential and the absence of licensed vaccines or
therapeutics. Among these prioritised pathogens is Zika</p>
<p>The Pathogen Epidemiology Review Group (PERG) has published a
systematic review for Zika, if you use any of our results please cite
our paper:</p>
<blockquote>
<p><span class="citation">@article</span>{zika_systematic_review_2025,
author = {Kelly McCain, Anna Vicco, Christian Morgenstern, Thomas
Rawson, Tristan M. Naidoo, Sangeeta Bhatia, Dominic P. Dee, Patrick
Doohan, Keith Fraser, Anna-Maria Hartner, Sequoia I. Leuba, Shazia
Ruybal-Pesántez, Richard J. Sheppard, H. Juliette T. Unwin, Kelly
Charniga, Zulma M. Cucunubá, Gina Cuomo-Dannenburg, Natsuko Imai-Eaton,
Edward S. Knock, Adam Kucharski, Mantra Kusumgar, Paul Liétar, Rebecca
K. Nash, Sabine van Elsland, Pathogen Epidemiology Review Group, Nuno R.
Faria, Anne Cori, Ruth McCabe, Ilaria Dorigatti},<br>
year={2025},<br>
title={A systematic review of Zika virus disease: epidemiological
parameters, mathematical models, and outbreaks},<br>
doi = {10.1101/2025.07.10.25331254},<br>
URL = {},<br>
eprint = {},<br>
journal = {medRxiv}<br>
}</p>
</blockquote>
<p>All Figures from the paper are re-produced below on the
<strong>latest</strong> available data in our data set. For convenience
we label the Figures with the same numbers as in the paper.</p>
<style type="text/css">
.flextable-shadow-host{
  overflow: scroll;
  white-space: nowrap;
}
</style>
<p><strong>Figure 1:</strong> Please see the pre-print for the the
PRISMA flowchart. This will remain static as data in the database is
updated.</p>
<div class="section level2">
<h2 id="overview-of-the-zika-outbreaks-and-seroprevalence">Overview of the Zika outbreaks and seroprevalence<a class="anchor" aria-label="anchor" href="#overview-of-the-zika-outbreaks-and-seroprevalence"></a>
</h2>
<p>ZIKV outbreak and seroprevalence mapping: (A) Countries with studies
reporting ZIKV outbreak information, coloured by number of studies.
Outbreaks reported in France and the Netherlands reflect outbreaks in
overseas regions. Countries with black diagonal stripes indicate
locations where ZIKV transmission has been reported by the WHO. (B)
Geolocated areas or regions with ZIKV seroprevalence studies (using IgG
assay, HAI/HI, MIA, NS1 BOB ELISA, IFA, capture ELISA and neutralisation
assays) conducted in the general population in the Americas (left),
Africa (centre) and Asia (right). Each dot represents a
location-specific estimate, while shaded areas indicate estimates at the
administrative unit level (region, province, district, or entire
country).</p>
<p><strong>Figure A: Outbreaks</strong></p>
<p><img src="pathogen_zika_files/figure-html/Figure_2A-1.png" alt="" width="1440"></p>
<p><strong>Figure B: Seroprevalence</strong></p>
<p><img src="pathogen_zika_files/figure-html/Figure_2B-1.png" alt="" width="1440"></p>
</div>
<div class="section level2">
<h2 id="overview-of-zika-reproduction-numbers-estimates">Overview of zika reproduction numbers estimates<a class="anchor" aria-label="anchor" href="#overview-of-zika-reproduction-numbers-estimates"></a>
</h2>
<p>R0 estimates by geographic location, type of sample, and population
group. Sub-national estimates for Brazil, Colombia, and French Polynesia
are shown in separate panels because of the high number of estimates;
all other estimates are shown in the respective continent panels.
Overall country estimates for Brazil, Colombia, and French Polynesia are
shown in the corresponding continent panels. Points are central
estimates reported in the published studies, error bars are 95%
confidence or credible intervals, thicker shaded bars are ranges of
central estimates over disaggregated groups. The grey vertical dotted
line marks 1. When multiple estimates for the same location were
available, the estimates were jittered.</p>
<p><strong>Figure 3A: Basic Reproduction numbers</strong></p>
<p><img src="pathogen_zika_files/figure-html/Figure_3-1.png" alt="" width="864"></p>
</div>
<div class="section level2">
<h2 id="epidemiological-delays-in-human-and-mosquitoes-">Epidemiological delays in human and mosquitoes.<a class="anchor" aria-label="anchor" href="#epidemiological-delays-in-human-and-mosquitoes-"></a>
</h2>
<p>Estimates by location and type of sample of Zika (A) intrinsic
incubation period, (B) infectious period, (C) serial interval, symptom
onset to admission, and symptom onset to recovery, and (D) admission to
discharge/recovery. Estimates by location and study of ZIKV extrinsic
incubation period in the mosquito (E). Points are the central estimates
reported in the studies, error bars are 95% confidence or credible
intervals, and shaded bars are ranges of central estimates over
disaggregated groups.</p>
<p><strong>Figure 4: Intrinsic incubation Period</strong>
<img src="pathogen_zika_files/figure-html/Figure_4A-1.png" alt="" width="864"></p>
<p><strong>Figure 4: Infectious Period</strong>
<img src="pathogen_zika_files/figure-html/Figure_4B-1.png" alt="" width="864"></p>
<p><strong>Figure 4: serial interval, symptom onset to admission, and
symptom onset to recovery delays</strong>
<img src="pathogen_zika_files/figure-html/Figure_4C-1.png" alt="" width="864"></p>
<p><strong>Figure 4: Admission to discharge/recovery</strong>
<img src="pathogen_zika_files/figure-html/Figure_4D-1.png" alt="" width="864"></p>
<p><strong>Figure 4: Extrinsic incubation period</strong>
<img src="pathogen_zika_files/figure-html/Figure_4E-1.png" alt="" width="864"></p>
</div>
<div class="section level2">
<h2 id="proportion-of-zika-congenital-syndrome-czs">Proportion of Zika congenital syndrome (CZS)<a class="anchor" aria-label="anchor" href="#proportion-of-zika-congenital-syndrome-czs"></a>
</h2>
<ol style="list-style-type: upper-alpha">
<li>Estimates of reported CZS proportions from Brazil (top) and the rest
of the world (bottom). Points are central estimates, solid lines are
confidence or credible intervals, and shaded segments are ranges of
central estimates across multiple groups. (B) Meta-analysis of CZS risk
stratified by population sample type. Red squares represent the observed
study effect sizes, the solid black horizontal lines are confidence
intervals, and blue diamonds are the pooled estimates for each sub-group
and overall. The vertical dashed line is the overall pooled
estimate.</li>
</ol>
<p><strong>Figure 5: CZS proportion given ZIKV-infected mothers</strong>
<img src="pathogen_zika_files/figure-html/Figure_5A-1.png" alt="" width="1152"></p>
<p><strong>Figure 5: meta-analysis on CZS proportion</strong>
<img src="pathogen_zika_files/figure-html/Figure_5B-1.png" alt="" width="864"></p>
</div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p></p>
<p>Developed by Rebecca Nash, Christian Morgenstern, Sangeeta Bhatia, Richard Sheppard, Joseph Hicks, Gina Cuomo-Dannenburg, Ruth McCabe, Kelly McCain, Anna Vicco, Patrick Doohan, Tristan Naidoo.</p>
</div>

<div class="pkgdown-footer-right">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.7.</p>
</div>

    </footer>
</div>

  

  

  </body>
</html>
